Seattle Genetics paid $43.3 million to purchase Bristol-Myers Squibb’s (BMS) pharmaceutical manufacturing facility in Bothell, WA. The facility, known as the Monte Villa Parkway Research Center, is a 51,000 square foot state-of-the art manufacturing and laboratory space built in 2014. Seattle Genetics plans to utilize the facility primarily for antibody production for current and future pipeline programs. As part of the transaction, the company intends to offer employment to the manufacturing fa...